Marketable Securities, Current of Indaptus Therapeutics, Inc. from 31 Mar 2022 to 30 Jun 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Indaptus Therapeutics, Inc. quarterly Marketable Securities, Current in USD history and change rate from 31 Mar 2022 to 30 Jun 2023.
Indaptus Therapeutics, Inc. Marketable Securities, Current for the quarter ending 30 Jun 2023 was $6,993,588, a 63% decline year-over-year.
Source SEC data: View on sec.gov

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Change (%)

Indaptus Therapeutics, Inc. Quarterly Marketable Securities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2023	$6,993,588	-$11,759,493	-63%	30 Jun 2023	10-Q	14 Aug 2023	2023	Q2
Q1 2023	$14,875,693	+$11,914,233	+402%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$16,806,009			31 Dec 2022	10-K	13 Mar 2024	2023	FY
Q3 2022	$21,742,040			30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$18,753,081			30 Jun 2022	10-Q	08 Aug 2022	2022	Q2
Q1 2022	$2,961,460			31 Mar 2022	10-Q	12 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.